Identification of a novel autoantigen in inflammatory bowel disease by protein microarray

Inflammatory Bowel Diseases

Volumn 17, Issue 6, 2011, Pages 1291-1300

  Vermeulen, Nathalie ^a   De Béeck, Katrijn Op ^a   Vermeire, Severine ^a   Steen, Kristel Van ^b,c   Michiels, Georges ^a   Ballet, Vera ^a   Rutgeerts, Paul ^a   Bossuyt, Xavier ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c Statistics and Epidemiology in Genetics Belgium   (Belgium)

Author keywords

antibodies; family with sequence similarity 84 member A; inflammatory bowel disease; protein microarray

Indexed keywords

ACTIVE BCR RELATED GENE TRANSCRIPT VARIANT 1; ANTIBODY; AUTOANTIGEN; CELL DIVISION CYCLE 2; CELL DIVISION CYCLE 2 TRANSCRIPT VARIANT 1; FAMILY WITH SEQUENCE SIMILARITY 84 MEMBER A; FAMILY WITH SEQUENCE SIMILARITY 84 MEMBER A ANTIBODY; FAMILY WITH SEQUENCE SIMILARITY 84 MEMBER C; MITOGEN ACTIVATED PROTEIN KINASE 8 INTERACTING PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; NECAP ENDOCYTOSIS ASSOCIATED 1; NEUTROPHIL CYTOPLASMIC ANTIBODY; P21 ACTIVATED KINASE 6; POLYADENYLIC ACID BINDING PROTEIN CYTOPLASMIC 3; PYRUVATE DEHYDROGENASE; RNA BINDING MOTIF PROTEIN 8A; SERINE THREONINE KINASE 40; TARGET OF MYB1 PROTEIN; TTK PROTEIN KINASE; TUBULIN GAMMA 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON RESECTION; CONTROLLED STUDY; CROHN DISEASE; DISEASE DURATION; ENTERITIS; FEMALE; GASTROINTESTINAL DISEASE; GEL ELECTROPHORESIS; HUMAN; IMMUNODETECTION; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; SMOKING HABIT; ULCERATIVE COLITIS; WESTERN BLOTTING;

AUTOANTIGENS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS;

EID: 79955788484     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21508     Document Type: Article

References (33)

1. Duerr RH, Targan SR, Landers CJ, et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology. 1991; 100: 1590-1596.
2. Vermeire S, Peeters M, Rutgeerts P., Diagnostic approach to IBD., Hepatogastroenterology 2000; 47: 44-48.
3. Sartor RB., Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am. 1995; 24: 475-507.
4. Bossuyt X., Serologic markers in inflammatory bowel disease. Clin Chem. 2006; 52: 171-181. (Pubitemid 43185477)
5. Saxon A, Shanahan F, Landers C, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990; 86: 202-210. (Pubitemid 20288725)
6. Rump JA, Scholmerich J, Gross V, et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology. 1990; 181: 406-413.
7. Main J, McKenzie H, Yeaman GR, et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ. 1988; 297: 1105-1106.
8. Stocker W, Otte M, Ulrich S, et al. Autoimmunity to pancreatic juice in Crohn's disease. Scand J Gastroenterol. 1987; 139: 41-52.
9. Seibold F, Weber P, Jenss H, et al. Antibodies to trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific marker for a subgroup of patients with Crohn's disease. Gut. 1991; 32: 1192-1197.
10. Klebl FH, Bataille F, Huy C, et al. Association of antibodies to exocrine pancreas with subtypes of Crohn's disease. Eur J Gastroenterol Hepatol. 2005; 17: 73-77. (Pubitemid 40128930)
11. Joossens S, Vermeire S, Van Steen K, et al. Pancreatic autoantibodies in inflammatory bowel disease. Inflamm Bowel Dis. 2004; 10: 771-777. (Pubitemid 39545223)
12. Lennard-Jones JE., Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989; 170 (suppl 24): 2-6. (Pubitemid 20015811)
13. Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001; 96: 730-734. (Pubitemid 32240723)
14. Zhu X, Gerstein M, Snyder M., ProCAT: a data analysis approach for protein microarrays. Genome Biol. 2006; 7: R110.
15. Robinson WH, DiGennaro C, Hueber W, et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med. 2002; 8: 295-301. (Pubitemid 34250109)
16. Hudson ME, Pozdnyakova I, Haines K, et al. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci U S A. 2007; 104: 17494-17499. (Pubitemid 350219866)
17. Vrabelova Z, Kolouskova S, Böhmova K, et al. Protein microarray analysis as a tool for monitoring cellular autoreactivity in type 1 diabetes patients and their relatives. Pediatr Diabetes. 2007; 8: 252-260. (Pubitemid 47422897)
18. Quintana FJ, Farez MF, Viglietta V, et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A. 2008; 105: 18889-18894.
19. Auger I, Balandraud N, Rak J, et al. New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA. Ann Rheum Dis. 2009; 68: 591-594.
20. Roggenbuck D, Hausdorf G, Martinez-Gamboa L, et al. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease. Gut. 2009; 58: 1620-1628.
21. Sakiyama T, Fujita H, Tsubouchi H., Autoantibodies against ubiquitination factor E4A (UBE4A) are associated with severity of Crohn's disease. Inflamm Bowel Dis. 2008; 14: 310-317. (Pubitemid 351441318)
22. Biancone L, Monteleone G, Marasco R, et al. Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives. Clin Exp Immunol. 1998; 113: 198-205. (Pubitemid 28352837)
23. Lundgren BA, Rorsman F, Portela-Gomes GM, et al. Identification of complement C3 as an autoantigen in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2010; 22: 429-436.
24. Kobayashi T, Masaki T, Sugiyama M, et al. A gene encoding a family with sequence similarity 84, member A (FAM84A) enhanced migration of human colon cancer cells. Int J Oncol. 2006; 29: 341-347.
25. Stöcker W, Otte M, Ulrich S, et al. Autoimmunity to pancreatic juice in Crohn's disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease. Scand J Gastroenterol Suppl. 1987; 139: 41-52.
26. Seibold F, Weber P, Jenss H, et al. Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease. Gut. 1991; 32: 1192-1197.
27. Hibi T, Ohara M, Kobayashi K, et al. Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease. Gut. 1994; 35: 224-230. (Pubitemid 24092869)
28. Folwaczny C, Noehl N, Tschöp K, et al. Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterology. 1997; 113: 101-106. (Pubitemid 27281763)
29. Sutton CL, Kim J, Yamane A, et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology. 2000; 119: 23-31. (Pubitemid 30452575)
30. Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005; 128: 2020-2028. (Pubitemid 40824710)
31. Ferrante M, Henckaerts L, Joossens M, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut. 2007; 56: 1394-1403. (Pubitemid 47517833)
32. Dotan I, Fishman S, Dgani Y, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut. 2007; 56: 1394-1403.
33. Papp M, Altorjay I, Dotan N, et al. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol. 2008; 103: 665-681. (Pubitemid 351405992)